December 02, 2022
Article
Specificity was between 93% to 97% and exceeded the threshold across all readers.
December 02, 2022
Article
“The outcomes were similar between those who had normal or above, or below normal testosterone levels at baseline," said Kelly L. Stratton, MD.
December 01, 2022
Article
OS was also found to be prolonged in the propensity score matched analysis, with a median that was not reached in the pembrolizumab arm vs 21 months in the IRC arm.
July 12, 2022
Article
The odds of a negative biopsy were 3.5 times higher when adding the androgen receptor pathway inhibitor to active surveillance.